Demet Duman-Cansaran
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Nanoparticle-Based miRNA Therapeutics in Breast Cancer Highlighting Design Strategies and Translational Potential.
Journal: International journal of nanomedicine
Published: May 11, 2026
Atranorin suppresses the LUCAT1/STAT3 axis to induce ferroptotic cell death in ovarian cancer.
Journal: Molecular biology reports
Published: May 10, 2026
Usnic Acid induces dual-pathway apoptosis in SKOV-3 ovarian cancer cells via PARP1 inhibition and MAPK pathway activation.
Journal: Human & experimental toxicology
Published: December 22, 2025
Unveiling the Anti-cancer Potential of Vulpinic Acid: A Selective Therapeutic Agent Against Oral Squamous Cell Carcinoma.
Journal: Current medicinal chemistry
Published: September 19, 2025
Comprehensive Evaluation of Usnic Acid as a Potential Drug Candidate for Triple-Negative Breast Cancer: Insights from Transcriptomic, Proteomic, and In Vivo Analyses.
Journal: Molecules (Basel, Switzerland)
Published: September 15, 2025
Pioneering of New Generation Therapies for Oral Cancer Involves the Integration of Small Molecules, Nanotechnology, and Artificial Intelligence - A Review.
Journal: Current medicinal chemistry
Published: July 15, 2025
Targeting the IL-6R/STAT3/PD-L1 axis: lobaric acid and Tocilizumab as a promising combination immunotherapy in ovarian cancer.
Journal: Molecular biology reports
Published: June 20, 2025
Amphibian Egg Jelly as a Biocompatible Material: Physicochemical Characterization and Selective Cytotoxicity Against Melanoma Cells.
Journal: Polymers
Published: June 20, 2025
Atranorin Triggers Intrinsic and Extrinsic Apoptosis and Suppresses Migration in Human Melanoma Cells.
Journal: Current medicinal chemistry
Published: June 09, 2025
Multifaceted interactions between lncRNA-associated ceRNA networks and small molecules in triple-negative breast cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 04, 2025
Evernic Acid: A Low-Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer.
Journal: Archiv der Pharmazie
Published: February 28, 2025
Targeting Ferroptosis with Small Molecule Atranorin (ATR) as a Novel Therapeutic Strategy and Providing New Insight into the Treatment of Breast Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 06, 2024
Last Updated: 09/26/2026